[VRTX] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
30-Oct-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -672.08%
YoY- -146.06%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 1,538,271 949,828 784,535 578,165 413,783 309,816 178,987 43.07%
PBT 745,871 70,666 136,511 -417,170 -42,034 -92,486 -166,577 -
Tax 78,437 13,148 8,055 -125,903 503 1,330 3,419 68.48%
NP 667,434 57,518 128,746 -102,952 -41,841 -95,149 -170,060 -
Tax Rate -10.52% -18.61% -5.90% - - - - -
Total Cost 870,837 892,310 655,789 681,117 455,624 404,965 349,047 16.44%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 43.39 6.06 16.41 -17.81 -10.11 -30.71 -95.01 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS 2.56 0.22 0.51 -0.41 -0.17 -0.39 -0.72 -
EPS Diluted 2.53 0.22 0.50 -0.41 -0.17 -0.39 -0.72 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.